Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1912 1
1913 1
1930 1
1950 1
1953 1
1954 1
1965 1
1966 1
1967 3
1968 2
1969 1
1970 2
1971 5
1972 2
1973 3
1974 5
1975 6
1976 8
1977 7
1978 9
1979 2
1980 3
1981 7
1982 5
1983 4
1984 9
1985 11
1986 11
1987 8
1988 10
1989 18
1990 15
1991 24
1992 20
1993 28
1994 22
1995 52
1996 25
1997 21
1998 27
1999 27
2000 18
2001 26
2002 25
2003 28
2004 38
2005 49
2006 47
2007 50
2008 43
2009 66
2010 67
2011 58
2012 76
2013 73
2014 80
2015 95
2016 95
2017 80
2018 89
2019 97
2020 124
2021 109
Text availability
Article attribute
Article type
Publication date

Search Results

1,689 results
Results by year
Filters applied: . Clear all
Page 1
Did you mean fh or facioscapulohumeral (16,950 results)?
Facioscapulohumeral muscular dystrophy.
Tawil R. Tawil R. Handb Clin Neurol. 2018;148:541-548. doi: 10.1016/B978-0-444-64076-5.00035-1. Handb Clin Neurol. 2018. PMID: 29478599 Review.
Facioscapulohumeral muscular dystrophy (FSHD) is one of the most common forms of muscular dystrophy with a distinctive pattern of skeletal muscle weakness and a wide spectrum of disease severity. ...The recent identification of aberrant activation of DUX4 transcript
Facioscapulohumeral muscular dystrophy (FSHD) is one of the most common forms of muscular dystrophy with a distinctive pattern
Therapeutic Strategies Targeting DUX4 in FSHD.
Le Gall L, Sidlauskaite E, Mariot V, Dumonceaux J. Le Gall L, et al. J Clin Med. 2020 Sep 7;9(9):2886. doi: 10.3390/jcm9092886. J Clin Med. 2020. PMID: 32906621 Free PMC article. Review.
Facioscapulohumeral muscular dystrophy (FSHD) is a common muscle dystrophy typically affecting patients within their second decade. ...Today there is no treatment available for FSHD patients and therapeutic strategies targeting DUX4 toxicity in skeletal muscl
Facioscapulohumeral muscular dystrophy (FSHD) is a common muscle dystrophy typically affecting patients within their second de
Facioscapulohumeral Muscular Dystrophy.
Statland JM, Tawil R. Statland JM, et al. Continuum (Minneap Minn). 2016 Dec;22(6, Muscle and Neuromuscular Junction Disorders):1916-1931. doi: 10.1212/CON.0000000000000399. Continuum (Minneap Minn). 2016. PMID: 27922500 Free PMC article. Review.
PURPOSE OF REVIEW: This article describes the clinical characteristics, diagnosis, molecular pathogenesis, and treatment of facioscapulohumeral muscular dystrophy (FSHD). RECENT FINDINGS: FSHD comprises two genetically distinct types that converge on a common …
PURPOSE OF REVIEW: This article describes the clinical characteristics, diagnosis, molecular pathogenesis, and treatment of facioscapuloh
Therapeutic Approaches in Facioscapulohumeral Muscular Dystrophy.
Cohen J, DeSimone A, Lek M, Lek A. Cohen J, et al. Trends Mol Med. 2021 Feb;27(2):123-137. doi: 10.1016/j.molmed.2020.09.008. Epub 2020 Oct 19. Trends Mol Med. 2021. PMID: 33092966 Free PMC article. Review.
Facioscapulohumeral muscular dystrophy (FSHD) is one of the most common types of muscular dystrophy, affecting roughly one in 8000 individuals. ...With combined advances across multiple facets of FSHD research, the field is now poised to accelerate the proces
Facioscapulohumeral muscular dystrophy (FSHD) is one of the most common types of muscular dystrophy, affecting roughly one in
Facioscapulohumeral Muscular Dystrophy.
DeSimone AM, Pakula A, Lek A, Emerson CP Jr. DeSimone AM, et al. Compr Physiol. 2017 Sep 12;7(4):1229-1279. doi: 10.1002/cphy.c160039. Compr Physiol. 2017. PMID: 28915324 Review.
While typically inherited as autosomal dominant, facioscapulohumeral muscular dystrophy (FSHD) has a complex genetic and epigenetic etiology that has only recently been well described. ...In this review, we describe recent advances in understanding the pathophysiolo …
While typically inherited as autosomal dominant, facioscapulohumeral muscular dystrophy (FSHD) has a complex genetic and epige …
Facioscapulohumeral Muscular Dystrophy: Update on Pathogenesis and Future Treatments.
Hamel J, Tawil R. Hamel J, et al. Neurotherapeutics. 2018 Oct;15(4):863-871. doi: 10.1007/s13311-018-00675-3. Neurotherapeutics. 2018. PMID: 30361930 Free PMC article. Review.
A reliable model of a disease pathomechanism is the first step to develop targeted treatment. In facioscapulohumeral muscular dystrophy (FSHD), the third most common muscular dystrophy, recent advances in understanding the complex genetics and epigenetics have led t …
A reliable model of a disease pathomechanism is the first step to develop targeted treatment. In facioscapulohumeral muscular dystrop …
Facioscapulohumeral Muscular Dystrophies.
Wagner KR. Wagner KR. Continuum (Minneap Minn). 2019 Dec;25(6):1662-1681. doi: 10.1212/CON.0000000000000801. Continuum (Minneap Minn). 2019. PMID: 31794465 Review.
PURPOSE OF REVIEW: Facioscapulohumeral muscular dystrophy (FSHD) is a common muscular dystrophy affecting both pediatric and adult patients. ...The distinctive phenotype of FSHD occurs secondary to two different genetic mechanisms. FSHD type 1 (FSHD1) …
PURPOSE OF REVIEW: Facioscapulohumeral muscular dystrophy (FSHD) is a common muscular dystrophy affecting both pediatric and a …
Facioscapulohumeral Muscular Dystrophy.
Fecek C, Emmady PD. Fecek C, et al. 2021 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan–. 2021 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan–. PMID: 32644454 Free Books & Documents. Review.
Facioscapulohumeral muscular dystrophy (FSHD) is a genetic illness inherited in an autosomal dominant fashion that affects skeletal muscle tissue in affected individuals. ...Beyond musculature, 50% of FSHD patients also present with subclinical high-frequency
Facioscapulohumeral muscular dystrophy (FSHD) is a genetic illness inherited in an autosomal dominant fashion that affects ske
Facioscapulohumeral muscular dystrophy (FSHD) molecular diagnosis: from traditional technology to the NGS era.
Zampatti S, Colantoni L, Strafella C, Galota RM, Caputo V, Campoli G, Pagliaroli G, Carboni S, Mela J, Peconi C, Gambardella S, Cascella R, Giardina E. Zampatti S, et al. Neurogenetics. 2019 May;20(2):57-64. doi: 10.1007/s10048-019-00575-4. Epub 2019 Mar 25. Neurogenetics. 2019. PMID: 30911870 Review.
Facioscapulohumeral muscular dystrophy (FSHD) is a genetic neuromuscular disorder which mainly affects the muscles of the face, shoulder, and upper arms. ...The diagnosis of FSHD requires therefore specific skills on both modern and less modern analytical pro
Facioscapulohumeral muscular dystrophy (FSHD) is a genetic neuromuscular disorder which mainly affects the muscles of the face
Genotype-phenotype correlations in FSHD.
Zernov N, Skoblov M. Zernov N, et al. BMC Med Genomics. 2019 Mar 13;12(Suppl 2):43. doi: 10.1186/s12920-019-0488-5. BMC Med Genomics. 2019. PMID: 30871534 Free PMC article. Review.
BACKGROUND: Facial-scapular-humeral myodystrophy Landouzy-Dejerine (FSHD) is an autosomal dominant disease, the basis of its pathogenesis is ectopic expression of the transcription factor DUX4 in skeletal muscle. ...CONCLUSIONS: Key pathogenesis factors have been identifie …
BACKGROUND: Facial-scapular-humeral myodystrophy Landouzy-Dejerine (FSHD) is an autosomal dominant disease, the basis of its pathogen …
1,689 results